These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1728615)

  • 1. Immunologic aspects of fibrosis in mouse mammary carcinomas.
    Vaage J
    Int J Cancer; 1992 Jan; 50(1):69-74. PubMed ID: 1728615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammary tumor immune enhancement in mice by local hyperemia.
    Vaage J
    Cancer Res; 1986 Jan; 46(1):386-9. PubMed ID: 3940204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunospecific eosinophil infiltration of a mouse mammary carcinoma.
    Vaage J; Pepin KG; Au TL
    Cancer Res; 1986 Oct; 46(10):5344-8. PubMed ID: 3756883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrosis in immune control of mammary-tumor growth.
    Vaage J
    Int J Cancer; 1992 May; 51(2):325-8. PubMed ID: 1568799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological observations during developing concomitant immunity against a C3H/He mammary tumor.
    Vaage J; Pepin KG
    Cancer Res; 1985 Feb; 45(2):659-66. PubMed ID: 3967241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of a cellular immune response in a highly cancer-susceptible C3H/He strain of mice and its nonfactor substrain C3H/f after the transplantation of a syngeneic mammary gland tumor].
    Razvorotneva VA; Lavrovskiĭ VA; Viksler VKh; Iurchenko IuA; Gruntenko EV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Oct; (10):68-73. PubMed ID: 228516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative abilities of athymic nude mice and severe combined immune deficient (SCID) mice to accept transplants of induced rat mammary carcinomas: enhanced transplantation efficiency of those rat mammary carcinomas that have elevated expression of neu oncogene.
    Oakley CS; Welsch MA; Zhai YF; Chang CC; Gould MN; Welsch CW
    Int J Cancer; 1993 Apr; 53(6):1002-7. PubMed ID: 8097186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
    Stutman O
    Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of tumour growth in two syngeneic C3H murine systems by immunization via the intracaecal route.
    Laursen ML; Laursen K
    Br J Cancer; 1978 Jun; 37(6):1039-45. PubMed ID: 678425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerated growth of mammary tumor cells in normal and athymic mice after treatment in vitro with dexamethasone.
    Gillette RW; Wunderlich DA
    Cancer Res; 1978 Oct; 38(10):3146-9. PubMed ID: 80260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of forphenicinol, a small molecular immunomodifier, in combination with cyclophosphamide on growth of and immunity to syngeneic murine tumors.
    Nitta K; Tanaka T; Takeuchi M
    Cancer Treat Rep; 1985 Mar; 69(3):285-91. PubMed ID: 3978657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spontaneous mammary carcinomas fail to induce an immune response in syngeneic FVBN202 neu transgenic mice.
    Kurt RA; Whitaker R; Baher A; Seung S; Urba WJ
    Int J Cancer; 2000 Sep; 87(5):688-94. PubMed ID: 10925363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of "eclipsed" lymphoid cells from advanced tumor-bearing mice through adoptive transfer to sublethally irradiated syngeneic hosts.
    Youn JK; Le Francois D; Hue G; Santillana M; Barski G
    Int J Cancer; 1975 Oct; 16(4):629-38. PubMed ID: 1176209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to breast cancer in mice immunized with X-irradiated breast cancer cells modified to secrete IL-12.
    Carr-Brendel V; Markovic D; Smith M; Taylor-Papadimitriou J; Cohen EP
    J Immunother; 1999 Sep; 22(5):415-22. PubMed ID: 10546157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local interleukin 2 therapy of mouse mammary tumors of various immunogenicities.
    Vaage J
    Cancer Res; 1988 Apr; 48(8):2193-7. PubMed ID: 3258187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene.
    Cavallo F; Giovarelli M; Gulino A; Vacca A; Stoppacciaro A; Modesti A; Forni G
    J Immunol; 1992 Dec; 149(11):3627-35. PubMed ID: 1358974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy of murine and human tumors in mice with lymphokines and interleukin-2-propagated lymphocytes.
    Kedar E; Chriqui-Zeira E; Kyriazis AP
    J Biol Response Mod; 1984 Oct; 3(5):517-26. PubMed ID: 6334139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-immunity between syngeneic tumors in mice immunized with gamma-irradiated ascites tumors.
    Kudo H; Waga T; Sato T; Ogasawara M; Ito I; Usubuchi I
    Tohoku J Exp Med; 1980 Jul; 131(3):285-8. PubMed ID: 7414608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A time factor in the success or failure of immune rejection of transplanted tumors.
    Vaage J
    Cancer Res; 1977 Apr; 37(4):1064-7. PubMed ID: 844038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.